이상훈
헬스케어부센터장
[ 소화기내과, 헬스케어센터, 췌담도센터, 소화기병센터(내시경실) ]
췌장, 담도 질환
예약 안내
2025.05
| 날짜 | |
|---|---|
| 오전 | |
| 오후 | |
외래진료 외래진료
특수클리닉 특수클리닉
논문
-
- Lee SH. Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicenter observational study. Therapeutic Advances in Medical Oncology. 2024 Sep 23;16:17588359241279688.
- Lee TY, Lee SH, Cheon YK. The Comparison of Clinical Outcomes in Elderly (≥75 Years) and Non-Elderly (<75 Years) Patients with Acute Cholangitis Due to Choledocholithiasis. Medicina. 2023 Dec;59(12):2171.
- Lee SH, Lee TY, Chung HW, Cheon YK. Effect of Rowachol on the Gallbladder Dysmotility Disorder Based on Gallbladder Ejection Fraction. Medicina. 2023 Jan;59(1):105.
- Kim JH, Lee TY, Lee SH, Chung HJ, Cheon YK. Effect of age on the prognosis of intrahepatic cholangiocarcinoma. Korean Journal of Internal Medicine. 2023 Jan;38(1):39-47.
- Lee SH, Cheon YK, Jung JH, Lee TY. Clinical Significance of the Neutrophil–Lymphocyte Ratio as an Early Predictive Marker for Adverse Outcomes in Patients with Acute Cholangitis. Medicina. 2022 Feb;58(2):255.
- Lee SH, Cheon YK, Lee TY. The Neutrophil-Lymphocyte Ratio as an Early Predictive Marker of the Severity of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Medicina. 2022 Jan;58(1):13.
- Lee SH. Long-term outcomes of fully covered self-expandable metal stents versus plastic stents in chronic pancreatitis. Scientific Reports. 2021 Aug 2;11:15637.
- Lee SH. Efficacy and Safety of Pembrolizumab for Gemcitabine/Cisplatin-Refractory Biliary Tract Cancer: A Multicenter Retrospective Study. Journal of Clinical Medicine. 2020 Jun;9(6):1769.